{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:43:20Z","timestamp":1784879000936,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.amjcard.2010.03.064","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T04:36:41Z","timestamp":1280983001000},"page":"517-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Meta-Analysis of Folic Acid Supplementation Trials on Risk of Cardiovascular Disease and Risk Interaction With Baseline Homocysteine Levels"],"prefix":"10.1016","volume":"106","author":[{"suffix":"III","given":"Edgar R.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Juraschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pastor-Barriuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia A.","family":"Bazzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2010.03.064_bib1","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjcard.2010.03.064_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.03.064_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ahj.2004.02.004","article-title":"Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials","volume":"148","author":"Splaver","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2010.03.064_bib4","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.03.064_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(07)70219-3","article-title":"Homocysteine-lowering therapy: a role in stroke prevention?","volume":"6","author":"Spence","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.amjcard.2010.03.064_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial","volume":"109","author":"den Heijer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2010.03.064_bib7","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.03.064_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.03.064_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/STROKEAHA.108.526798","article-title":"High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial","volume":"40","author":"Hodis","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2010.03.064_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0218492309102494","article-title":"Folic acid-based intervention in non-ST elevation acute coronary syndromes","volume":"7","author":"Imasa","year":"2009","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.amjcard.2010.03.064_bib11","unstructured":"Collins R. SEARCH. (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine): randomized comparison of folic acid 2 mg plus vitamin B12 1 mg daily versus placebo for 7 years in 12,064 myocardial infarction survivors. Presented at a meeting of the American Heart Association, late breaking trials; New Orleans; November 9, 2008. Available at: http:\/\/directnews.americanheart.org\/extras\/pdfs\/search_slides.pdf."},{"key":"10.1016\/j.amjcard.2010.03.064_bib12","series-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"key":"10.1016\/j.amjcard.2010.03.064_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib14","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods","volume":"8","author":"Thompson","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib15","first-page":"159","article-title":"Meta-analysis for trend estimation","volume":"15","author":"Shi","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2010.03.064_bib17","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/j.amjcard.2010.03.064_bib18","first-page":"741S","article-title":"Blinded comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial (abstract)","volume":"106","author":"Baker","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.03.064_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2003.02.001","article-title":"Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial","volume":"93","author":"Liem","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2010.03.064_bib20","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart Study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.03.064_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.03.064_bib23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2004.035030","article-title":"Secondary prevention with folic acid: results of the goes extension study","volume":"91","author":"Liem","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2010.03.064_bib24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/aje\/kwj090","article-title":"Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function","volume":"15","author":"Guallar","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjcard.2010.03.064_bib26","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMe068060","article-title":"Homocysteine trials\u2014clear outcomes for complex reasons","volume":"354","author":"Loscalzo","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1515\/CCLM.2007.337","article-title":"Management of L-dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? results from a review","volume":"45","author":"Zoccolella","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib28","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1515\/CCLM.2003.230","article-title":"Measurement of carotid plaque and effect of vitamin therapy for total homocysteine","volume":"41","author":"Spence","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1017\/S0007114507777140","article-title":"Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK","volume":"98","author":"Wright","year":"2007","journal-title":"Br J Nutr"},{"key":"10.1016\/j.amjcard.2010.03.064_bib30","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.297.21.2351","article-title":"Folic acid for the prevention of colorectal adenomas: a randomized clinical trial","volume":"297","author":"Cole","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.03.064_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00191-0","article-title":"Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?","volume":"165","author":"Doshi","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2010.03.064_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1474-4422(07)70200-4","article-title":"Is homocysteine a causal and treatable risk factor for stroke?","volume":"6","author":"Hankey","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.amjcard.2010.03.064_bib33","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/STROKEAHA.108.529503","article-title":"Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial","volume":"40","author":"Saposnik","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2010.03.064_bib34","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2010.03.064_bib35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ajcn\/82.4.717","article-title":"Do low doses of folic acid result in maximum lowering of homocysteine?","volume":"82","author":"Bailey","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.amjcard.2010.03.064_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-135-2-200107170-00014","article-title":"Power shortage: clinical trials testing the \u201chomocysteine hypothesis\u201d against a background of folic acid-fortified cereal grain flour","volume":"135","author":"Bostom","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib37","first-page":"1575","article-title":"Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis","volume":"45","author":"Clarke","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.amjcard.2010.03.064_bib38","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","year":"2005","journal-title":"Am J Clin Nutr"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914910008520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914910008520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:20:42Z","timestamp":1757571642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914910008520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0002914910008520"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2010.03.064","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of Folic Acid Supplementation Trials on Risk of Cardiovascular Disease and Risk Interaction With Baseline Homocysteine Levels","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2010.03.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}